Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma
Clinical trial NCT00003513 · TERMINATED
Trial details
- NCT number
- NCT00003513
- Sponsor
- Burzynski Research Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1996-12-16
- Primary completion
- 1999-03-29
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.